These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23075248)

  • 1. Neurochemical dementia diagnostics for Alzheimer's disease and other dementias: an ISO 15189 perspective.
    Waedt J; Kleinow M; Kornhuber J; Lewczuk P
    Biomark Med; 2012 Oct; 6(5):685-90. PubMed ID: 23075248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International quality control survey of neurochemical dementia diagnostics.
    Lewczuk P; Beck G; Ganslandt O; Esselmann H; Deisenhammer F; Regeniter A; Petereit HF; Tumani H; Gerritzen A; Oschmann P; Schröder J; Schönknecht P; Zimmermann K; Hampel H; Bürger K; Otto M; Haustein S; Herzog K; Dannenberg R; Wurster U; Bibl M; Maler JM; Reubach U; Kornhuber J; Wiltfang J
    Neurosci Lett; 2006 Nov; 409(1):1-4. PubMed ID: 17045397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?
    Lewczuk P; Kornhuber J
    Expert Rev Proteomics; 2011 Aug; 8(4):447-58. PubMed ID: 21819301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics.
    Zimmermann R; Beck G; Knispel S; Maler JM; Weih M; Wiltfang J; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2010; 19(4):1199-203. PubMed ID: 20308786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical dementia diagnostics: State of the art and research perspectives.
    Lewczuk P; Wiltfang J
    Proteomics; 2008 Mar; 8(6):1292-301. PubMed ID: 18271068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective.
    Lewczuk P; Mroczko B; Fagan A; Kornhuber J
    Adv Med Sci; 2015 Mar; 60(1):76-82. PubMed ID: 25579841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers.
    Lewczuk P; Zimmermann R; Wiltfang J; Kornhuber J
    J Neural Transm (Vienna); 2009 Sep; 116(9):1163-7. PubMed ID: 19653063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of CSF biomarkers in the diagnostics of memory diseases].
    Remes A; Leikola M; Majamaa K; Nikkanen M; Ruokonen LI; Rusanen M; Tapiola T; Ylikotila P; Vallittu AM; Pirttilä T
    Duodecim; 2009; 125(20):2215-22. PubMed ID: 19998760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New biomarkers for Alzheimer's disease in cerebrospinal fluid and blood].
    Vogelgsang J; Wiltfang J
    Nervenarzt; 2019 Sep; 90(9):907-913. PubMed ID: 31407045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarkers in spinal fluid of patients with dementia].
    Skogseth RE; Fladby T; Mulugeta E; Aarsland D
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2235-8. PubMed ID: 22085948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia.
    Engelborghs S; Le Bastard N
    J Neurol Sci; 2012 Nov; 322(1-2):197-9. PubMed ID: 22947896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of neurochemical dementia diagnostics in CSF compared to 99mTc-SPECT in Alzheimer's dementia].
    Weih M; Krinninger M; Zimmermann R; Lewczuk P; Svitek J; Schaller G; Degirmenci U; Richter-Schmidinger T; Wiltfang J; Kuwert T; Kornhuber J; Schmidt D
    Fortschr Neurol Psychiatr; 2009 Jul; 77(7):407-11. PubMed ID: 19582652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Vanderstichele H; Bibl M; Engelborghs S; Le Bastard N; Lewczuk P; Molinuevo JL; Parnetti L; Perret-Liaudet A; Shaw LM; Teunissen C; Wouters D; Blennow K
    Alzheimers Dement; 2012 Jan; 8(1):65-73. PubMed ID: 22047631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers reflecting different facets of Alzheimer's disease.
    Zetterberg H
    Eur J Neurol; 2008 Nov; 15(11):1143-4. PubMed ID: 18973609
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.
    Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Boulanghien J; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Perret-Liaudet A; Touchon J; Lehmann S
    J Alzheimers Dis; 2011; 26(3):553-63. PubMed ID: 21709372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
    Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
    Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.
    Lewczuk P; Kamrowski-Kruck H; Peters O; Heuser I; Jessen F; Popp J; Bürger K; Hampel H; Frölich L; Wolf S; Prinz B; Jahn H; Luckhaus Ch; Perneczky R; Hüll M; Schröder J; Kessler H; Pantel J; Gertz HJ; Klafki HW; Kölsch H; Reulbach U; Esselmann H; Maler JM; Bibl M; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2010 Feb; 15(2):138-45. PubMed ID: 18663368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.
    del Campo M; Mollenhauer B; Bertolotto A; Engelborghs S; Hampel H; Simonsen AH; Kapaki E; Kruse N; Le Bastard N; Lehmann S; Molinuevo JL; Parnetti L; Perret-Liaudet A; Sáez-Valero J; Saka E; Urbani A; Vanmechelen E; Verbeek M; Visser PJ; Teunissen C
    Biomark Med; 2012 Aug; 6(4):419-30. PubMed ID: 22917144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.
    Johansson P; Mattsson N; Hansson O; Wallin A; Johansson JO; Andreasson U; Zetterberg H; Blennow K; Svensson J
    J Alzheimers Dis; 2011; 24(3):537-46. PubMed ID: 21297262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.